Advertise on podcast: Diabetech - Diabetes Tech, Research, News

Gary and I take on one of the most important skills in modern diabetes management: understanding and using your data. We break down how to analyze CGM and pump data to identify patterns, trends, and problem areas without getting overwhelmed by numbers. The conversation covers basal insulin, bolus timing, insulin to carb ratios, correction factors, and what metrics like time in range and glucose variability actually tell you about your settings. We also discuss when to make adjustments on your own and when to involve a diabetes educator.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (today's sponsor)*   Learn About Integrated Diabetes (Gary’s Practice)   Send in YOUR questions!   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Using biometrics like heart rate, stress, and activity to automate insulin delivery in real time, Rheos is a next-generation AID system designed to learn and adapt directly from the body. I sit down with Jonathan Fitch, Founder of GlucoSense, to explore how this settings-free, AI-powered AID system uses wearable data to continuously adapt insulin needs throughout the day. We get into features like logging meals by photo or voice, planning workouts through an in-app LLM, and how the system dynamically adjusts dosing based on real physiological signals. Jonathan also shares how a life-threatening seizure during college pushed him to rethink diabetes automation—and how that experience shaped Rheos’ goal of dramatically reducing the daily management burden.   Learn about the Eversense 365 CGM   T1D Exchange Registry Sign up  (US residents only)   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Insulin pump access in the U.S. is changing fast, with more companies moving to pharmacy benefits and making it easier than ever for people with diabetes to start—or switch—systems. While this shift brings more choice and flexibility, it’s also exposing serious challenges around safety, training, and continuity of care. As AID systems become more complex and less interchangeable, switching pumps isn’t as simple as transferring settings anymore. In this episode, Diana Isaacs, PharmD, CDCES joins me to break down what’s really happening as pump transitions become more frequent and why both users and healthcare providers are feeling the strain. We talk about why confusion is increasing, where transitions often go wrong, and what needs to change to make pump switching safer and more effective for everyone.   Learn about the Eversense 365 CGM   Sell your collection to Markest    Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

Co-host Gary Scheiner, CDCES, and I break down basal insulin and why it is the foundation of insulin therapy. We explain what basal insulin does, how it controls liver glucose between meals and overnight, and why incorrect settings can cause constant highs and lows even with advanced diabetes tech. We also cover common basal insulin mistakes, how pumps and automated insulin delivery systems handle basal differently, and answer listener questions about what your data can tell you when basal is off.   Learn about Omnipod 5 (today's sponsor)*   Learn About Integrated Diabetes (Gary’s Practice)   Send in YOUR questions!   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

2025 delivered major innovations in diabetes tech as well as surprising twists and today we explore the wins, the fails, and what these trends mean for people living with diabetes. I sit down with Kamil Armacky of Nerdabetic to unpack everything from Libre 3 Plus expanding pump integrations, updates and sensor recall, to Dexcom’s new 15-day sensor and how the community feels about it. We also dive into major industry shifts, including Medtronic Diabetes separating to form MiniMed, Omnipod’s roadmap for Omnipod 6 and beyond, and Eversense taking full control of its implantable business. This is a big one!   Learn about Omnipod 5 (today's sponsor)*   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

What happens when diabetes tech doesn’t do what you need—and you decide to build the solution yourself? I sit down with Pablo Medina, who was recently diagnosed with type 1.5 diabetes and built his own iPhone app to fix gaps in insulin patch tracking. We get into his misdiagnosis journey, his experience with devices like InPen, Cequr Simplicity, and why he’s now trialing the Omnipod 5 AID system. Pablo walks me through how his insulin patch tracker app works, the challenges of building and publishing a diabetes app, and why patient-driven innovation matters. This conversation highlights what happens when people with diabetes combine lived experience with technical skills to push diabetes technology forward.   Learn about Omnipod 5 (today's sponsor)*   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Medtronic, soon-to-be MiniMed, officially launched its brand-new Instinct CGM in the U.S., a 15-day, no-calibration sensor that pairs seamlessly with the 780G insulin pump. I sit down with Medtronic’s Laura Endres to break down everything. Laura gives us a live demo of the Instinct applicator, explains how it integrates with both the 780G and the upcoming MiniMed Go smart pen platform, and shares why Medtronic partnered with Abbott to bring this sensor to market so quickly. We also get into how Instinct compares to Simplera, why users might choose one over the other, and what the roadmap looks like for next-generation pumps, algorithms, and the upcoming MiniMed spin-off.   Learn about Omnipod 5 (today's sponsor)*   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

On our new show Optimizing Diabetes Tech (ODT) my co-host Gary Scheiner CDCES and I discuss how people with diabetes can take full advantage of their continuous glucose monitors to make managing Diabetes easier and safer. We get into how to react to alarms, adjust settings, and the features you need to know about. We also answer your questions about CGMs.   Learn about Omnipod 5 (today's sponsor)*   Learn About Integrated Diabetes Services (Gary’s Practice)   Send us YOUR questions!   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I sit down with Josiah Dykstra—a cybersecurity expert who spent nearly two decades at the NSA and has lived with type 1 diabetes for over 30 years—to explore what diabetes management looks like inside some of the most locked-down buildings in the world. We talk about what happens when your phone, smartwatch, and even certain medical devices are banned; why a standalone Dexcom receiver became essential for his T1D care; and how government security teams decide which pumps, CGMs, pacemakers, and hearing aids are safe enough to enter classified spaces. Josiah opens up about his long-standing fears around pump hacking, why early insulin pump vulnerabilities shook the cybersecurity world, how risk decisions are made at the highest levels, and what finally convinced him to consider automated insulin delivery. We also dig into FDA regulation, the evolving state of medical device cybersecurity, and what all of this means for the future of diabetes tech.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I sit down with endocrinologist and diabetes tech expert Dr. David Ahn to unpack the future of tubeless insulin pumps and automated insulin delivery for people with type 1 diabetes. We break down how companies like Omnipod, Tandem (with its tubeless Mobi and 7-day infusion set), Beta Bionics with its reusable mint patch pump, and Medtronic’s upcoming MiniMed Fit are racing to own the next generation of patch pumps. We talk about what Omnipod needs to do with its next-gen system to stay competitive, why 7-day wear and reusable parts matter, and how algorithms—from Loop to iLet—are evolving toward more hands-off, closed-loop insulin delivery. We also dig into big questions around dual-hormone systems using glucagon, how far current CGM technology can really take us, and whether fully closed-loop insulin pump systems without carb counting are actually realistic.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

I sit down with Breakthrough T1D CEO Dr. Aaron Kowalski to trace his journey—from open-source roots and the early CGM days to leading one of the most influential organizations in diabetes. We dig into how the Artificial Pancreas Project helped make CGMs and AID systems mainstream, and why Aaron believes he’ll one day take off his insulin pump. He breaks down today’s cure pathways—cell replacement and regeneration, immune modulation, and prevention—plus Project ACT to accelerate cell therapies. We also cover the stages of type 1 diabetes and the latest on teplizumab, alongside the push for dynamic algorithms and smarter insulins.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Pregnancy with diabetes can feel overwhelming—and our healthcare system doesn’t always provide the support people need. In this episode, I talk with Kari Cao and Kelly Carter from RenewRx, a platform transforming prenatal care with behavior-based coaching, CGM insights, and real-time support for both patients and providers. It’s a heartwarming conversation about how they’re filling the gaps in our healthcare system and empowering women through one of the most important journeys of their lives.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Researchers are pushing the boundaries of noninvasive glucose monitoring—by looking to the brain. In this episode, I speak with Dr. Casey Halpern, founder and CEO of SynchNeuro, a startup developing a small wearable that sits behind the ear and reads brainwave activity (EEG) to track glucose levels. The device interprets electrical signals from the hypothalamus and other brain regions to detect shifts in glucose, stress, and metabolism in real time. Early testing suggests accuracy close to today’s CGMs—but without the needle. Dr. Halpern shares how this technology works, what’s next in development, and why brain-based monitoring could redefine the future of wearable health tech.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Before CGM data hit Apple Watches or official apps, Kate Farnsworth and a community of determined parents made it happen themselves. Labeled “helicopter parents” by companies Dexcom, they soldered devices, coded software, and launched Nightscout—the first way to view glucose data remotely. Kate went on to found the Looped Facebook group helping over 30,000 families build their own open-source insulin systems years before commercial AID pumps existed. In this episode, Kate shares how DIY innovation transformed her relationship with her daughter, pushed regulators like Health Canada to adapt, and ultimately led her to work inside medtech with Beta Bionics and Sequel MedTech (makers of the twiist pump). It’s the story of how passion, code, and community changed diabetes care forever.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

The twiist insulin pump from Sequel Med Tech is finally in users’ hands—and people have thoughts! I sas down with two early adopters, Sean Wilkinson and nurse practitioner Jori Matushek, to discuss their first month using twiist. They dive into everything from the algorithm’s unique features—like emoji-based bolusing and retroactive carb adjustments—to infusion set design, occlusion detection, and how it feels to wear. The trio also breaks down their glucose results, user experience with the Libre 3 Plus CGM, and how easy (or not) it was to get on the system. Whether you’re pump shopping or just curious about what makes twiist different, this conversation has you covered.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   Sean's twiist Patch Hack   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.